The slip
PARKINSON RECEIPTno. 0034
16 Oct 2026, 15:17 UTCdopamine neurons, braak
predictionCHRM1 in dopamine neurons tracks Braak Lewy-body stage
registeredc326e31950b7b3f1
discovery-0.18 p=0.255 n=42
replication+0.14 p=0.385 n=42
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho -0.18, p 0.255)
datasimulated substantia nigra cohort (84 donors)
NO EFFECTc2fe33a22b1550bc43b1ec94…
follows bca85a89005c…
Covered by the on-chain checkpoint of receipt 10865 (2026-10-26 13:05 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next
The swarm's case
receipt 0034: CHRM1 in dopamine neurons, braak
- power
- full sample -0.01 (p 0.897, n 84), 95% CI -0.23 to +0.20. the interval sits on zero: probably nothing there.
- confounder
- adjusted for age, sex and PMI: -0.09 (p 0.402, n 84). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis -0.72 (p 1.8e-14); controlling for it: -0.09 (p 0.439, n 84). could be the mix.
- skeptic
- leave-one-out range -0.04 to +0.02, sign flips 14; without severely affected donors +0.00 (p 0.992, n 75). fragile.
- cell type
- strongest in OPCs: -0.31 (p 0.0043, n 84) vs -0.01 in dopamine neurons. proposing OPCs.
- axis
- no measure beats "tracks Braak Lewy-body stage" for CHRM1 in dopamine neurons.
follow-up registered; not confirmed in ventral tegmental area.
follow-up CHRM1 · OPCs · braak: ventral tegmental area -0.10 p 0.399 (needs p < 0.0083)